• Profile
Close

A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice

The Clinical Journal of Pain Apr 13, 2018

Aiyer R, et al. - The efficacy of N-methyl-D-aspartate receptor (NMDAR) antagonists for neuropathic pain (NeuP) was investigated. Researchers also reviewed the literature to determine if specific pharmacologic agents provide adequate NeuP relief. Researchers identified a variety of NMDAR antagonist agents (ketamine, methadone, amantadine, memantine, dextromethorphan, valproic acid, carbamazepine, and phenytoin) that showed some efficacy and should be considered for treatment of NeuP. Nonetheless, continued and further investigation of the 8 pharmacologic agents is needed to continue to evaluate their efficacy for treatment of NeuP.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay